Byrd, Kenneth, and Phu Truong. “Bortezomib in the Treatment of Acquired Von Willebrand Disease Secondary to Monoclonal Gammopathy of Undetermined Significance”. Kansas Journal of Medicine 7, no. 4 (November 6, 2014): 167–170. Accessed May 3, 2024. https://journals.ku.edu/kjm/article/view/11507.